18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines

European Journal of Pharmacology

Volumn 649, Issue 1-3, 2010, Pages 354-361

  Lee, Chung Soo ^a   Yang, Jae Chon ^a   Kim, Yun Jeong ^a   Jang, Eun Ra ^a   Kim, Wonyong ^a   Myung, Soon Chul ^b  

^a Chung Ang University   (South Korea)

^b Chung Ang University College of Medicine   (South Korea)

Author keywords

Apoptosis related protein; Epithelial ovarian adenocarcinoma cell line; Synergistic effect; Trichostatin A

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; PROTEIN BCL 2; PROTEIN BID; PROTEIN P53; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL ASSAY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CELL SURVIVAL; DNA FRAGMENTATION; DRUG SYNERGISM; ENZYME ACTIVATION; FEMALE; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MITOCHONDRIA; OVARIAN NEOPLASMS; PRODRUGS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 78049276760     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.09.047     Document Type: Article

References (41)

1. Agarwal M.K., Iqbal M., Athar M. Inhibitory effect of 18β-glycyrrhetinic acid on 12-O-tetradecanoyl phorbol-13-acetate-induced cutaneous oxidative stress and tumor promotion in mice. Redox Rep. 2005, 10:151-157.
2. Albihn A., Mo H., Yang Y., Henriksson M. Camptothecin-induced apoptosis is enhanced by Myc and involves PKCδ signaling. Int. J. Cancer 2007, 121:1821-1829.
3. Andrisano V., Ballardini R., Hrelia P., Cameli N., Tosti A., Gotti R., Cavrini V. Studies on the photostability and in vitro phototoxicity of Labetalol. Eur. J. Pharm. Sci. 2001, 12:495-504.
4. Arnold N.B., Arkus N., Gunn J., Korc M. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer. Clin. Cancer Res. 2007, 13:18-26.
5. Camins A., Pallas M., Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Fin. Exp. Clin. Pharmacol. 2008, 30:43-65.
6. Chipuk J.E., Green D.R. Dissecting p53-dependent apoptosis. Cell Death Differ. 2006, 13:994-1002.
7. Cui X.S., Jeong Y.J., Lee H.Y., Cheon S.H., Kim N.H. Fetal bovine serum influences apoptosis and apoptosis-related gene expression in porcine parthenotes developing in vitro. Reproduction 2004, 127:125-130.
8. Curreli F., Friedman-Kien A.E., Flore O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J. Clin. Invest. 2005, 115:642-652.
9. de Groot G., Koops R., Hogendoorn E.A., Goewie C.E., Savelkoul T.J., van Vloten P. Improvement of selectivity and sensitivity by column switching in the determination of glycyrrhizin and glycyrrhetic acid in human plasma by high-performance liquid chromatography. J. Chromatogr. 1988, 456:71-81.
10. Duan H., Heckman C.A., Boxer L.M. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell Biol. 2005, 25:1608-1619.
11. Glaser K.B. HDAC inhibitors: clinical update and mechanism-based potential. Biochem. Pharmacol. 2007, 74:659-671.
12. Gumpricht E., Dahl R., Devereaux M.W., Sokol R. Licorice compounds glycyrrhizin and 18β-glycyrrhetinic acid are potent modulators of bile acid-induced cytotoxicity in rat hepatocytes. J. Biol. Chem. 2005, 280:10556-10563.
13. Hibasami H., Iwase H., Yoshioka K., Takahashi H. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int. J. Mol. Med. 2005, 233-236.
14. Hibasami H., Iwase H., Yoshioka K., Takahashi H. Glycyrrhetinic acid (a metabolic substance and aglycon of glycyrrhizin) induces apoptosis in human hepatoma, promyelotic leukemia and stomach cancer cells. Int. J. Mol. Med. 2006, 17:215-219.
15. Hoever G., Baltina L., Michaelis M., Kondratenko R., Baltina L., Tolstikov G.A., Doerr H.W., Cinatl J. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J. Med. Chem. 2005, 48:1256-1259.
16. Hu W., Kavanagh J.J. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 2003, 4:721-729.
17. Ishiwata S., Nakashita K., Ozawa Y., Niizeki M., Nozaki S., Tomioka Y., Mizugaki M. Fas-mediated apoptosis is enhanced by glycyrrhizin without alteration of caspase-3-like activity. Biol. Pharm. Bull. 1999, 22:1163-1166.
18. Jeong H.G., You H.J., Park S.J., Moon A.R., Chung Y.C., Kang S.K., Chun H.K. Hepatoprotective effects of 18β-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol. Res. 2002, 46:221-227.
19. Kinjo J., Hirakawa T., Tsuchihashi R., Nagao T., Okawa M., Nohara T., Okabe H. Hepatoprotective constituents in plants. 14. Effects of soyasapogenol B, sophoradiol, and their glucuronides on the cytotoxicity of tert-butyl hydroperoxide to HepG2 cells. Biol. Pharm. Bull. 2003, 26:1357-1360.
20. Kumar K.S., Sonnemann J., Beck J.F. Histone deacetylase inhibitors induce cell death in supratentorial primitive neuroectodermal tumor cells. Oncol. Rep. 2006, 16:1047-1052.
21. Lee C.S., Kim Y.J., Lee M.S., Han E.S., Lee S.J. 18β-Glycyrrhetinic acid induces apoptotic cell death in SiHa cells and exhibits a synergistic effect against antibiotic anti-cancer drug toxicity. Life Sci. 2008, 41:481-489.
22. Makino T., Tsubouchi R., Murakami K., Haneda M., Yoshino M. Generation of reactive oxygen species and induction of apoptosis of HL60 cells by ingredients of traditional herbal medicine, Sho-saiko-to. Basic Clin. Pharmacol. Toxicol. 2006, 98:401-415.
23. Matsui S., Matsumoto H., Sonoda Y., Ando K., Aizu-Yokota E., Sato T., Kasahara T. Glycyrrhizin and related compounds down-regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int. Immunopharmacol. 2004, 15:1633-1644.
24. McClusky L.M. Fetal bovine serum simultaneously stimulates apoptosis and DNA synthesis in premeiotic stages of spermatogenesis in spiny dogfish (Squalus acanthias) in vitro: modulation by androgen and spermatogenic activity status. Apoptosis 2008, 13:649-658.
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
26. Nagai T., Egashira T., Yamanaka Y., Kohno M. The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch. Environ. Contam. Toxicol. 1991, 20:432-436.
27. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5408-5412.
28. Pan L., Lu J., Wang X., Han L., Zhang Y., Han S., Huang B. Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer 2007, 109:1676-1688.
29. Platta C.S., Greenblatt D.Y., Kunnimalaiyaan M., Chen H. The HDAC inhibitor trichostatin A inhibits growth of small cell lung cancer cells. J. Surg. Res. 2007, 142:219-226.
30. Rasheed W.K., Johnstone R.W., Prince H.M. Histone deacetylase inhibitors in cancer therapy. Expert Opin. Investig. Drugs 2007, 16:659-678.
31. Rosato R.R., Grant S. Histone deacetylase inhibitors in cancer therapy. Cancer Biol. Ther. 2003, 2:30-37.
32. Ruefli A.A., Ausserlechner M.J., Bernhard D., Sutton V.R., Tainton K.M., Kofler R., Smyth M.J., Johnstone R.W. The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:10833-10838.
33. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 2000, 120:849-862.
34. Sonnemann J., Kumar K.S., Heesch S., Müller C., Hartwig C., Maass M., Bader P., Beck J.F. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int. J. Oncol. 2006, 28:755-766.
35. Sonnemann J., Hüls I., Sigler M., Palani C.D., Hong le T.T., Völker U., Kroemer H.K., Beck J.F. Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells. Oncol. Rep. 2008, 20:219-224.
36. van Rossum T.G., Vulto A.G., Hop W.C., Schalm S.W. Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection. Clin. Ther. 1999, 21:2080-2090.
37. Wiman K.G. Strategies for therapeutic targeting of the p53 pathway in cancer. Cell Death Differ. 2006, 13:921-926.
38. Wu Z.Q., Zhang R., Chao C., Zhang J.F., Zhang Y.Q. Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin. Med. J. 2007, 120:2112-2118.
39. Yamamura Y., Kawakami J., Santa T., Kotaki H., Uchino K., Sawada Y., Tanaka N., Iga T. Pharmacokinetic profile of glycyrrhizin in healthy volunteers by a new high-performance liquid chromatographic method. J. Pharm. Sci. 1992, 81:1042-1046.
40. Yim S.B., Park S.E., Lee C.S. Protective effect of glycyrrhizin on 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death in differentiated PC12 cells. J. Pharmacol. Exp. Ther. 2007, 321:816-822.
41. Yoshikawa M., Toyohara M., Ueda S., Shirol A., Takeuchi H., Nishiyama T., Yamada T., Fukui H., Ishizaka S. Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2. Biol. Pharm. Bull. 1999, 22:951-955.